Both in Biotechnology
Allogene Therapeutics vs Editas Medicine
Over the past year ALLO returned +7.2% and EDIT returned −2.2%; their daily moves had a correlation of 0.47.
ALLO +7.2% EDIT −2.2%Growth of $1, one year, split-adjusted
| Metric | ALLO | EDIT |
|---|---|---|
| Price | $1.19 | $2.72 |
| Market cap | $411.1M | $417.7M |
| Today | +6.25% | +4.62% |
| 1 month | −18.5% | −0.4% |
| 6 months | −48.5% | −14.3% |
| Year to date | −13.1% | +32.7% |
| 1 year | +0.8% | −11.1% |
| Revenue growth (YoY) | — | +232.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −919.8% | −153.3% |
| P/E (TTM) | — | — |
| Price / sales | 88.6× | 8.9× |
| Net cash | $332.6M | $155.9M |
| Dividend yield | — | — |
| Volatility (60d) | 56.2% | 81.5% |
| Short % of float | 19.4% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).